시장보고서

상품코드

1651980

세계의 암 종양 프로파일링 시장 : 규모, 점유율, 동향, 업계 분석(암유형별, 기술별, 수법별, 용도별, 지역별), 예측(2025-2034년)

Cancer or Tumor Profiling Market Size, Share, Trends, Industry Analysis Report: By Cancer Type, Technology, Technique, Application, and Region - Market Forecast, 2025-2034

발행일: 2025년 01월 | 리서치사:

Polaris Market Research | 페이지 정보: 영문 116 Pages | 배송안내 : 1-2일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면 세계 암 종양 프로파일링 시장 규모는 2034년까지 353억 6,000만 달러에 이를 것으로 예상됩니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.

암 종양 프로파일링 시장의 확대는 세계의 암 유병률 증가와 맞춤형 의료에 대한 수요 증가가 원동력이 되고 있습니다. 주요 촉진요인으로는 조기 발견, 더 나은 진단, 보다 치밀한 치료를 가능하게 하는 차세대 시퀀싱(NGS) 및 리퀴드 바이옵시와 같은 유전체 기술의 진보가 포함됩니다. 암 종양 프로파일링 시장 기회는 신흥 시장에 존재하며, 거기서는 의료 액세스나 인지도의 향상이 암 프로파일링 기술의 채용을 뒷받침하고 있습니다.

데이터 분석을 위한 인공지능(AI)의 통합과 비침습적 진단 기법에 대한 주목이 높아지는 등의 동향이 시장을 형성하고 있습니다. 바이오마커 탐색의 지속적인 기술 혁신과 정밀진단에 대한 규제당국의 지원은 개별화된 보다 효과적인 치료전략을 통해 환자의 결과를 개선하는데 중점을 두게 되어 시장이 지속적으로 확대될 전망입니다.

암 종양 프로파일링 시장 : 분석 개요

유방암 부문은 높은 유병률과 개인화 치료 및 유전체 프로파일 링에 대한 수요가 증가함에 따라 암 종양 프로파일 링 시장에서 가장 큰 점유율을 차지합니다. 그러나 폐암 부문은 조기 발견과 표적 치료를 위한 리퀴드 바이옵시와 선진 유전체 프로파일링의 이용 증가에 따라 가장 높은 성장을 기록하고 있습니다.

기술별로 차세대 시퀀서(NGS) 분야가 시장을 독점하고 있으며 종양의 유전자 프로파일에 대한 종합적인 통찰력을 제공하고 정밀 종양학을 추진하고 있습니다. 중합효소 연쇄반응(PCR) 분야는 그 비용효과와 조기암발생을 위한 리퀴드 바이옵시에의 응용에 힘쓰고 가장 빠르게 성장하고 있는 기술분야입니다.

기법별로 유전체학 분야는 맞춤형 의료에 필수적인 돌연변이, 유전자 발현, 종양 불균일성에 관한 상세한 분자 데이터를 제공하는 능력에 의해 암 종양 프로파일링 시장의 수익 점유율을 선도하고 있습니다. 후성유전학 분야는 암의 진행과 치료에 대한 반응을 촉진하는 분자 메커니즘의 해명에 있어서의 역할에 의해 가장 높은 성장을 이루고 있습니다.

용도별로는 맞춤형 의료 분야가 시장을 독점하고 있습니다. 치료방침의 결정이나 환자의 결과 개선을 위해, 유전체 및 바이오마커에 근거한 검사를 채용하는 종양의가 증가하고 있기 때문입니다. 바이오마커 탐색 분야는 암의 조기 발견과 진행 모니터링을 위해 보다 정밀하고 새로운 바이오마커가 확인되고 있어 급속히 성장하고 있습니다.

북미가 가장 큰 시장 점유율을 차지하고 있으며, 그 배경에는 첨단 의료 인프라와 정밀 종양학에 대한 강한 관심이 있습니다. 아시아태평양은 의료 접근성 증가, 암 이환율 증가, 암 프로파일링 기술 채택 확대로 가장 빠르게 성장하는 시장입니다.

시장 현황
암 종양 프로파일링 시장 역학
- 성장 촉진요인과 기회
  - 진단에 있어서의 액체 생검의 통합
  - 차세대 시퀀싱(NGS)의 역할 확대
- 억제요인과 과제
  - 프로파일링 기술의 고비용
PESTLE 분석
세계의 암 종양 프로파일링 시장 동향
밸류체인 분석
COVID-19의 영향 분석

제5장 세계의 암 종양 프로파일링 시장 : 암유형별

주요 분석 결과
소개
유방암
폐암
대장암
전립선암
흑색종 암
기타

제6장 세계의 암 종양 프로파일링 시장 : 기술별

주요 분석 결과
소개
차세대 시퀀싱(NGS)
중합효소 연쇄반응(PCR)
면역조직화학(IHC)
인사이츄 하이브리드화(ISH)
마이크로어레이
기타

제7장 세계의 암 종양 프로파일링 시장 : 수법별

주요 분석 결과
소개
유전체학
단백질체학
후성 유전학
대사체학

제8장 세계의 암 종양 프로파일링 시장 : 용도별

주요 분석 결과
소개
맞춤형 의료
진단
바이오마커 발견
예측
기타

제9장 세계의 암 종양 프로파일링 시장 :지역별

주요 분석 결과
소개
- 세계의 암 종양 프로파일링 시장의 평가:지역별(2020-2034년)
북미
- 북미 : 암유형별(2020-2034년)
- 북미 : 기술별(2020-2034년)
- 북미 : 수법별(2020-2034년)
- 북미 : 용도별(2020-2034년)
- 미국
- 캐나다
유럽
- 유럽 : 암유형별(2020-2034년)
- 유럽 : 기술별(2020-2034년)
- 유럽 : 수법별(2020-2034년)
- 유럽 : 용도별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
아시아태평양
- 아시아태평양: 암유형별(2020-2034년)
- 아시아태평양 : 기술별(2020-2034년)
- 아시아태평양: 수법별(2020-2034년)
- 아시아태평양: 용도별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 중동 및 아프리카 : 암유형별(2020-2034년)
- 중동 및 아프리카 : 기술별(2020-2034년)
- 중동 및 아프리카: 수법별(2020-2034년)
- 중동 및 아프리카: 용도별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
라틴아메리카
- 라틴아메리카 : 암유형별(2020-2034년)
- 라틴아메리카 : 기술별(2020-2034년)
- 라틴아메리카 : 수법별(2020-2034년)
- 라틴아메리카 : 용도별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카

제10장 경쟁 구도

사업 확대 및 기업 인수 분석
- 사업 확대
- 기업 인수
제휴,협업,합의,공개

제11장 기업 프로파일

Illumina
Thermo Fisher Scientific
Qiagen
F. Hoffmann-La Roche
Agilent Technologies
Bio-Rad Laboratories
PerkinElmer
Foundation Medicine(a Roche subsidiary)
Guardant Health
NeoGenomics Laboratories
Pacific Biosciences
Personalis
GRAIL(a subsidiary of Illumina)
Invitae
Genomic Health(a subsidiary of Exact Sciences)

SHW 25.03.10

The global cancer or tumor profiling market size is expected to reach USD 35.36 billion by 2034, according to a new study by Polaris Market Research. The report "Cancer or Tumor Profiling Market Size, Share, Trends, Industry Analysis Report: By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Others), Technology, Technique, Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The cancer or tumor profiling market expansion is driven by the increasing prevalence of cancer worldwide and the growing demand for personalized medicine. Key drivers include advancements in genomic technologies such as next-generation sequencing (NGS) and liquid biopsy, which enable early detection, better diagnosis, and more targeted treatments. Cancer or tumor profiling market opportunities exist in emerging markets, where rising healthcare access and awareness are boosting the adoption of cancer profiling technologies.

Trends such as the integration of artificial intelligence (AI) for data analysis and the growing focus on noninvasive diagnostic techniques are shaping the market. With ongoing innovations in biomarker discovery and regulatory support for precision diagnostics, the market is poised for continued expansion, with a heightened emphasis on improving patient outcomes through personalized and more effective treatment strategies.

Cancer or Tumor Profiling Market Report Highlights

The breast cancer segment, by cancer type, holds the largest cancer or tumor profiling market share due to its high prevalence and the growing demand for personalized treatments and genomic profiling. However, the lung cancer segment is registering the highest growth due to the increasing use of liquid biopsy and advanced genomic profiling for early detection and targeted therapies.

By technology, the next-generation sequencing (NGS) segment dominates the market, offering comprehensive insights into tumor genetic profiles and driving precision oncology. The polymerase chain reaction (PCR) segment is the fastest-growing technology segment, fueled by its cost-effectiveness and application in liquid biopsy for early cancer detection.

The genomics segment, based on technique, leads the cancer or tumor profiling market revenue share due to its ability to provide in-depth molecular data on mutations, gene expressions, and tumor heterogeneity, which are critical for personalized medicine. The epigenetics segment is experiencing the highest growth, driven by its role in uncovering molecular mechanisms that drive cancer progression and response to treatment.

In terms of application, the personalized medicine segment dominates the market, as more oncologists adopt genomic and biomarker-based testing to guide treatment decisions and improve patient outcomes. The biomarker discovery segment is growing rapidly as new and more precise biomarkers are being identified for early detection and monitoring of cancer progression.

North America holds the largest market share, supported by its advanced healthcare infrastructure and strong focus on precision oncology. Asia Pacific is the fastest-growing market, driven by increasing healthcare access, rising cancer rates, and expanding adoption of cancer profiling technologies.

Polaris Market Research has segmented the cancer or tumor profiling market report on the basis of cancer type, technology, technique, application, and region:

By Cancer Type Outlook (Revenue - USD Billion, 2020-2034)

Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Melanoma Cancer
Others

By Technology Outlook (Revenue - USD Billion, 2020-2034)

Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In-Situ Hybridization (ISH)
Microarray
Others

By Technique Outlook (Revenue - USD Billion, 2020-2034)

Genomics
Proteomics
Epigenetics
Metabolomics

By Application Outlook (Revenue - USD Billion, 2020-2034)

Personalized Medicine
Diagnostics
Biomarker Discovery
Prognostics
Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Cancer or Tumour Profiling Market Insights

4.1. Global Cancer or Tumour Profiling Market - Market Snapshot
4.2. Global Cancer or Tumour Profiling Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Integration of Liquid Biopsy in Diagnostics
  - 4.2.1.2. Growing Role of Next-Generation Sequencing (NGS)
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Cost of Profiling Technologies
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Global Cancer or Tumour Profiling Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Cancer or Tumour Profiling Market, by Cancer Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
5.3. Breast Cancer
- 5.3.1. Global Cancer or Tumour Profiling Market, by Breast Cancer, by Region, 2020-2034 (USD Billion)
5.4. Lung Cancer
- 5.4.1. Global Cancer or Tumour Profiling Market, by Lung Cancer, by Region, 2020-2034 (USD Billion)
5.5. Colorectal Cancer
- 5.5.1. Global Cancer or Tumour Profiling Market, by Colorectal Cancer, by Region, 2020-2034 (USD Billion)
5.6. Prostate Cancer
- 5.6.1. Global Cancer or Tumour Profiling Market, by Prostate Cancer, by Region, 2020-2034 (USD Billion)
5.7. Melanoma Cancer
- 5.7.1. Global Cancer or Tumour Profiling Market, by Melanoma Cancer, by Region, 2020-2034 (USD Billion)
5.8. Others
- 5.8.1. Global Cancer or Tumour Profiling Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Cancer or Tumour Profiling Market, by Technology

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
6.3. Next-Generation Sequencing (NGS)
- 6.3.1. Global Cancer or Tumour Profiling Market, by Next-Generation Sequencing (NGS), by Region, 2020-2034 (USD Billion)
6.4. Polymerase Chain Reaction (PCR)
- 6.4.1. Global Cancer or Tumour Profiling Market, by Bakery & Confectionary, by Region, 2020-2034 (USD Billion)
6.5. Immunohistochemistry (IHC)
- 6.5.1. Global Cancer or Tumour Profiling Market, by Immunohistochemistry (IHC), by Region, 2020-2034 (USD Billion)
6.6. In-Situ Hybridization (ISH)
- 6.6.1. Global Cancer or Tumour Profiling Market, by In-Situ Hybridization (ISH), by Region, 2020-2034 (USD Billion)
6.7. Microarray
- 6.7.1. Global Cancer or Tumour Profiling Market, by Microarray, by Region, 2020-2034 (USD Billion)
6.8. Others
- 6.8.1. Global Cancer or Tumour Profiling Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Cancer or Tumour Profiling Market, by Technique

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
7.3. Genomics
- 7.3.1. Global Cancer or Tumour Profiling Market, by Genomics, by Region, 2020-2034 (USD Billion)
7.4. Proteomics
- 7.4.1. Global Cancer or Tumour Profiling Market, by Proteomics, by Region, 2020-2034 (USD Billion)
7.5. Epigenetics
- 7.5.1. Global Cancer or Tumour Profiling Market, by Epigenetics, by Region, 2020-2034 (USD Billion)
7.6. Metabolomics
- 7.6.1. Global Cancer or Tumour Profiling Market, by Metabolomics, by Region, 2020-2034 (USD Billion)

8. Global Cancer or Tumour Profiling Market, by Application

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
8.3. Personalized Medicine
- 8.3.1. Global Cancer or Tumour Profiling Market, by Personalized Medicine, by Region, 2020-2034 (USD Billion)
8.4. Diagnostics
- 8.4.1. Global Cancer or Tumour Profiling Market, by Diagnostics, by Region, 2020-2034 (USD Billion)
8.5. Biomarker Discovery
- 8.5.1. Global Cancer or Tumour Profiling Market, by Biomarker Discovery, by Region, 2020-2034 (USD Billion)
8.6. Prognostics
- 8.6.1. Global Cancer or Tumour Profiling Market, by Prognostics, by Region, 2020-2034 (USD Billion)
8.7. Others
- 8.7.1. Global Cancer or Tumour Profiling Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Cancer or Tumour Profiling Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Global Cancer or Tumour Profiling Market Assessment, By Geography, 2020-2034 (USD billion)
9.3. Global Cancer or Tumour Profiling Market - North America
- 9.3.1. North America: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
- 9.3.2. North America: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
- 9.3.3. North America: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
- 9.3.4. North America: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.3.5. Global Cancer or Tumour Profiling Market - US
  - 9.3.5.1. US: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.3.5.2. US: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.3.5.3. US: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.3.5.4. US: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.3.6. Global Cancer or Tumour Profiling Market - Canada
  - 9.3.6.1. Canada: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.3.6.2. Canada: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.3.6.3. Canada: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.3.6.4. Canada: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
9.4. Global Cancer or Tumour Profiling Market - Europe
- 9.4.1. Europe: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
- 9.4.2. Europe: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
- 9.4.3. Europe: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
- 9.4.4. Europe: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.4.5. Global Cancer or Tumour Profiling Market - UK
  - 9.4.5.1. UK: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.4.5.2. UK: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.4.5.3. UK: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.4.5.4. UK: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.4.6. Global Cancer or Tumour Profiling Market - France
  - 9.4.6.1. France: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.4.6.2. France: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.4.6.3. France: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.4.6.4. France: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.4.7. Global Cancer or Tumour Profiling Market - Germany
  - 9.4.7.1. Germany: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.4.7.2. Germany: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.4.7.3. Germany: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.4.7.4. Germany: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.4.8. Global Cancer or Tumour Profiling Market - Italy
  - 9.4.8.1. Italy: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.4.8.2. Italy: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.4.8.3. Italy: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.4.8.4. Italy: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.4.9. Global Cancer or Tumour Profiling Market - Spain
  - 9.4.9.1. Spain: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.4.9.2. Spain: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.4.9.3. Spain: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.4.9.4. Spain: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.4.10. Global Cancer or Tumour Profiling Market - Netherlands
  - 9.4.10.1. Netherlands: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.4.10.2. Netherlands: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.4.10.3. Netherlands: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.4.10.4. Netherlands: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.4.11. Global Cancer or Tumour Profiling Market - Russia
  - 9.4.11.1. Russia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.4.11.2. Russia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.4.11.3. Russia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.4.11.4. Russia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.4.12. Global Cancer or Tumour Profiling Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.4.12.2. Rest of Europe: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.4.12.3. Rest of Europe: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.4.12.4. Rest of Europe: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
9.5. Global Cancer or Tumour Profiling Market - Asia Pacific
- 9.5.1. Asia Pacific: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
- 9.5.2. Asia Pacific: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
- 9.5.3. Asia Pacific: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
- 9.5.4. Asia Pacific: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.5.5. Global Cancer or Tumour Profiling Market - China
  - 9.5.5.1. China: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.5.5.2. China: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.5.5.3. China: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.5.5.4. China: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.5.6. Global Cancer or Tumour Profiling Market - India
  - 9.5.6.1. India: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.5.6.2. India: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.5.6.3. India: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.5.6.4. India: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.5.7. Global Cancer or Tumour Profiling Market - Malaysia
  - 9.5.7.1. Malaysia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.5.7.2. Malaysia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.5.7.3. Malaysia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.5.7.4. Malaysia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.5.8. Global Cancer or Tumour Profiling Market - Japan
  - 9.5.8.1. Japan: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.5.8.2. Japan: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.5.8.3. Japan: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.5.8.4. Japan: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.5.9. Global Cancer or Tumour Profiling Market - Indonesia
  - 9.5.9.1. Indonesia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.5.9.2. Indonesia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.5.9.3. Indonesia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.5.9.4. Indonesia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.5.10. Global Cancer or Tumour Profiling Market - South Korea
  - 9.5.10.1. South Korea: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.5.10.2. South Korea: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.5.10.3. South Korea: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.5.10.4. South Korea: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.5.11. Global Cancer or Tumour Profiling Market - Australia
  - 9.5.11.1. Australia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.5.11.2. Australia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.5.11.3. Australia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.5.11.4. Australia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.5.12. Global Cancer or Tumour Profiling Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.5.12.2. Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.5.12.3. Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.5.12.4. Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
9.6. Global Cancer or Tumour Profiling Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
- 9.6.2. Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
- 9.6.3. Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
- 9.6.4. Middle East & Africa: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.6.5. Global Cancer or Tumour Profiling Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.6.5.2. Saudi Arabia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.6.5.3. Saudi Arabia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.6.5.4. Saudi Arabia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.6.6. Global Cancer or Tumour Profiling Market - UAE
  - 9.6.6.1. UAE: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.6.6.2. UAE: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.6.6.3. UAE: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.6.6.4. UAE: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.6.7. Global Cancer or Tumour Profiling Market - Israel
  - 9.6.7.1. Israel: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.6.7.2. Israel: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.6.7.3. Israel: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.6.7.4. Israel: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.6.8. Global Cancer or Tumour Profiling Market - South Africa
  - 9.6.8.1. South Africa: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.6.8.2. South Africa: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.6.8.3. South Africa: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.6.8.4. South Africa: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.6.9. Global Cancer or Tumour Profiling Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.6.9.2. Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.6.9.3. Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.6.9.4. Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
9.7. Global Cancer or Tumour Profiling Market - Latin America
- 9.7.1. Latin America: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
- 9.7.2. Latin America: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
- 9.7.3. Latin America: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
- 9.7.4. Latin America: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.7.5. Global Cancer or Tumour Profiling Market - Mexico
  - 9.7.5.1. Mexico: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.7.5.2. Mexico: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.7.5.3. Mexico: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.7.5.4. Mexico: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.7.6. Global Cancer or Tumour Profiling Market - Brazil
  - 9.7.6.1. Brazil: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.7.6.2. Brazil: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.7.6.3. Brazil: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.7.6.4. Brazil: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.7.7. Global Cancer or Tumour Profiling Market - Argentina
  - 9.7.7.1. Argentina: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.7.7.2. Argentina: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.7.7.3. Argentina: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.7.7.4. Argentina: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.7.8. Global Cancer or Tumour Profiling Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.7.8.2. Rest of Latin America: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.7.8.3. Rest of Latin America: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.7.8.4. Rest of Latin America: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Illumina
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Thermo Fisher Scientific
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Qiagen
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. F. Hoffmann-La Roche
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Agilent Technologies
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Bio-Rad Laboratories
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. PerkinElmer
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Foundation Medicine (a Roche subsidiary)
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Guardant Health
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. NeoGenomics Laboratories
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Pacific Biosciences
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Personalis
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13. GRAIL (a subsidiary of Illumina)
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
11.14. Invitae
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
11.15. Genomic Health (a subsidiary of Exact Sciences)
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development